Skip to main content

Table 3 Summary of main findings

From: The role of specific biomarkers, as predictors of post-operative complications following flexible ureterorenoscopy (FURS), for the treatment of kidney stones: a single-centre observational clinical pilot-study in 37 patients

➢ A significant increase in NGAL concentration post-FURS for the management of nephrolithiasis (p = 0.034).
➢ No significant differences were seen in Cystatin C, MPO or PCT concentrations post-FURS, for the management of nephrolithiasis (p > 0.05)